Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
For weight management, eligibility, nutrition support, tolerability, and long-term maintenance become central
Individual results may differ based on dose tolerance, health history, nutrition, activity, treatment adherence, and other factors
According to FDA labeling for Wegovy (semaglutide), patients should be evaluated after 12 weeks at the maintenance dose (2.4 mg weekly), with discontinuation considered if less than 5% body weight reduction has been achieved
Platform communication takes place through account portals and scheduled telehealth interactions rather than open-ended messaging
Potential side effects leading to dose reductions before maximum effects seen
US$ 27.66
US$ 22.82
US$ 29.69
US$ 27.77
US$ 24.12
US$ 29.42
US$ 27.29
US$ 22.66
US$ 26.07
US$ 23.75
